Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4255 Prognostic significance of nodal micrometastases in patients with non-functioning pancreatic neuroendocrine tumors (NF-PanNETs) – A survival analysis from a prospective observational study

Introduction: Nodal metastases (N+) are one of the most powerful predictors of disease recurrence after surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs). However, the prognostic role of nodal metastases

Conference:

Presenting Author: Andreasi V

Authors: Andreasi V, Partelli S, Schiavo Lena M, Muffatti F, Battistella A,

Keywords: nodal metastases, micrometastases, surgery, prognosis, recurrence, pancreatic neuroendocrine,

#3873 Prognostic significance of nodal micro metastases in patients with non-functioning pancreatic neuroendocrine tumors (NF-PanNETs)

Introduction: Nodal metastases are one of the most powerful predictors of disease recurrence after surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs). However, the prognostic role of nodal metastases measuring

Conference:

Presenting Author:

Authors: Andreasi V, Partelli S, Muffatti F, Giannone F, Palumbo D,

Keywords: PanNET, nodal metastases, surgery, recurrence, micro metastasis,

#3436 Prognostic factors in 382 patients treated with 177-Lu-DOTATATE: Data from the SEPTRALU registry

Introduction: The aim was to describe prognostic variables in patients treated with 177Lu-DOTATATE (PRRT).

Conference:

Presenting Author:

Authors: Pubul V, Belló P, Hernando J, Rodeño E, Gajate P,

Keywords: somatostatin receptor-positive tumor, PRRT, prognostic variables,

#3417 SARS-CoV-2 vaccination site as possible pitfall on somatostatin receptor imaging

Introduction: SARS-CoV-2 (COVID19) vaccinations have shown high efficacy. Therefore, increased chances exist that patients undergoing Peptide Receptor Radionuclide Therapy (PRRT) or radionuclide imaging for Neuroendocrine Tumors (NETs) may have being recently vaccinated.

Conference:

Presenting Author: Kolade O

Authors: Kolade O, Ayeni A, Brink A, Steyn R, Prasad V,

Keywords: COVID-19, SARS-CoV-2, Lu-177 DOTATATE, Ga-68 DOTANOC, Vaccination, PRRT, Neuroendocrine Tumor,

#3228 Sensitivity of 68Ga-DOTATATE PET in detecting primary tumor and nodal metastases in surgically resected lung carcinoids

Introduction: 68Ga-DOTATATE positron emission tomography (PET) is increasingly employed in staging of lung carcinoids prior to surgery.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Rakshit S

Authors: Rakshit S, Lee K, Kendi A, Wigle D, Leventakos K,

Keywords: DOTATATE PET, staging, carcinoid,